The Full Spectrum of News.
Published loading...Updated

Fewer than half of Americans trust FDA, CDC to do their job

  • On May 6, 2025, FDA Commissioner Marty Makary announced the agency’s skeptical approach to this year’s COVID-19 booster approval in Washington, D.C.
  • The FDA demands rigorous clinical trials rather than relying on antibody spikes, reflecting public concerns about booster effectiveness and low uptake.
  • The agency, having doubled staff since 2007 to 19,000 employees, considers limiting boosters to high-risk groups amid hesitation and 85% of healthcare workers declining the last booster.
  • Makary highlighted that relying on data from clinical trials conducted several years ago is insufficient, and called for a streamlined and effective FDA that prioritizes public safety.
  • This cautious stance could delay booster availability for the next respiratory season and signals challenges in restoring public trust and improving vaccine uptake.
Insights by Ground AI
Does this summary seem wrong?

19 Articles

All
Left
3
Center
9
Right
4
InsideNoVA.comInsideNoVA.com
+10 Reposted by 10 other sources
Center

COVID Boosters Might Not Be Updated For Next Season, FDA Commissioner Says

Key Takeaways

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources are Center
56% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Hill broke the news in Washington, United States on Tuesday, May 6, 2025.
Sources are mostly out of (0)